June 30, 2008 - OrthoNeutrogena announced that the Food and Drug Administration has approved its collagen-based facial filler Evolence for the correction of moderate-to-deep wrinkles and folds.
Evolence has been available in Canada, Western and Eastern Europe, Israel, South Korea and Russia since 2004. It will be introduced in the United States throughout the second half of 2008.
Dr. Carney now has Evolence in the office and was trained for the product earlier this spring. Please call if you would like to make an appointment to be one of the first to benefit from this product.
